OTLK - Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm | Benzinga
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc. ("Outlook" or the "Company") (NASDAQ:OTLK) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Outlook stock. Outlook investors are encouraged to